Substipharm Overview

  • Year Founded
  • 1995

Year Founded

  • Status
  • Private

  • Employees
  • 150

Employees

  • Latest Deal Type
  • Debt

Substipharm General Information

Description

Developer, manufacturer, and distributor of generic, niche, and mature pharmaceuticals intended to provide more affordable healthcare and to improve access to medicines. The company offers a wide range of pharmaceutical products and dossiers including over-the-counter pharmaceuticals, food, and dietary supplements, and prescription brands, thereby enabling clients with products that cover almost all core therapeutic areas.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Private Debt Financed
Corporate Office
  • 24 rue Erlanger
  • 75016 Paris
  • France
+33 01
Primary Industry
Pharmaceuticals
Corporate Office
  • 24 rue Erlanger
  • 75016 Paris
  • France
+33 01

Substipharm Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Substipharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Debt - General Completed Generating Revenue
2. Debt - Acquisition 09-Sep-2025 Completed Generating Revenue
1. Debt - General 15-Oct-2024 $388M $388M Completed Generating Revenue
To view Substipharm’s complete valuation and funding history, request access »

Substipharm Patents

Substipharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4062907-A1 Formulation for oral administration of ivermectin and uses thereof Inactive 23-Mar-2021
EP-4313155-A1 Oral formulation of ivermectin and uses thereof Pending 23-Mar-2021
WO-2022200402-A1 Oral formulation of ivermectin and uses thereof Inactive 23-Mar-2021
ES-2978020-T3 A pharmaceutical composition comprising racecadotril and a method of preparing the same Active 06-Mar-2017
EP-3592333-A1 A pharmaceutical composition comprising racecadotril and process for preparing the same Active 06-Mar-2017 A61K31/216
To view Substipharm’s complete patent history, request access »

Substipharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Substipharm Investments & Acquisitions (6)

Substipharm’s most recent deal was a Corporate Asset Purchase with Opella (Aspégic). The deal was made on 31-Oct-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Opella (Aspégic) 31-Oct-2025 Corporate Asset Purchase Buildings and Property
Sanofi (Kardégic) 31-Oct-2025 Corporate Asset Purchase Buildings and Property
Vectans Pharma 01-Jul-2025 Merger/Acquisition Drug Delivery
IMOJEV 30-Nov-2022 Corporate Asset Purchase Buildings and Property
Speciality European Pharma (Mitem) 27-Apr-2017 Corporate Asset Purchase Buildings and Property
You’re viewing 5 of 6 investments and acquisitions. Get the full list »

Substipharm Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Indigo Therapeutics Paris, France 2015

Substipharm FAQs

  • When was Substipharm founded?

    Substipharm was founded in 1995.

  • Where is Substipharm headquartered?

    Substipharm is headquartered in Paris, France.

  • What is the size of Substipharm?

    Substipharm has 150 total employees.

  • What industry is Substipharm in?

    Substipharm’s primary industry is Pharmaceuticals.

  • Is Substipharm a private or public company?

    Substipharm is a Private company.

  • What is Substipharm’s current revenue?

    The current revenue for Substipharm is .

  • How much funding has Substipharm raised over time?

    Substipharm has raised $388M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process